Trulieve Receives Backlash Online From Alleged Employees Over Handling Of COVID-19

It appears that Trulieve Cannabis (CSE: TRUL) is facing a slight public relations issue currently. Earlier today, what appears to be an employee of the company took to Reddit an announcement that there has allegedly been multiple employees at their Florida dispensaries that have tested positive for coronavirus. Allegations made by the poster include that the company has not been forthcoming with telling other employees that they may have had a shift or contact with the affected individuals.

Additional complaints made by the poster include the statement that hazard pay has not been provided for the essential workers, and that a large portion of employees are labeled as part time. The result of which is that benefits are said to be “sparse if available at all.”

Similar sentiment was reinforced by several other posters on the Reddit thread, by both what appears to be employees and patients alike, however employment was not verified. One poster claimed to be an employee at a different location which is claimed to have had positive cases among employees. It’s stated that no facility shutdown occurred after the positive cases were registered, with employees stated as being scared to show up to work and managers walking out.

With respect to patients, there were several complaints in the thread related to the waiting room and the time required to be inside. While the company notably has what appears to be a “text and go” system in place for those who wish to use it, it appears to be heavily flawed in that several commentators reported waiting for times of up to twenty minutes in crowded rooms, despite being alerted that their order was ready.

In the name of balanced reporting however, it appears that issues for customers at the very least appear to be limited to certain stores only, with some commentators identifying no issues in terms of wait times at their local dispensaries.

A copy of an email sent by Trulieve to employees.

While none of the claims have been verified individually by The Deep Dive, it seems that the company appears to be going through some pain in relation to the ongoing pandemic, as can be expected to a certain extent. However, many reports indicate that the company appears to remain focused on sales more than that of safety, despite soaring infection rates within the state.

Trulieve Cannabis last traded at $19.50 on the CSE.


Information for this briefing was found via Reddit. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

4 Responses

  1. I received no text after placing order for Lady Lake store ,I went to the store 3 hours later ,still wasn’t ready . The manager came out and said it will be a minute because of me her workers had to leave the register to get my order from the back and its inconvivnecing the store…she recommended I place walk in order from now on.. .i was speechless

Video Articles

SSR Mining Walks Away From a World Class Gold-Copper Project

Why More Canadians Are Starting to Think About Leaving | Jesse Day

Instead of Waiting, This Gold Developer Went Bigger | Kenneth McLeod – Sonoro Gold

Recommended

Questcorp Sharpens La Union Targets With Expanded IP Survey

Why This Gold Company Keeps Spinning Out Assets | John-Mark Staude – Riverside Resources

Related News

Trulieve Trims Losses In Q2 2024, Thanks To Stronger Revenue

Trulieve Cannabis (CSE: TRUL) has reported an improvement in its financial results for the second...

Tuesday, August 6, 2024, 10:11:00 AM

US Cannabis: Earnings Preview For The Oncoming Fourth Quarter Results

March is turning out to be a busy month in public cannabis, with many of...

Monday, March 8, 2021, 04:10:00 PM

Trulieve Prices Public Offering At C$198.1 Million

Trulieve Cannabis (CSE: TRUL) this evening released the pricing of their previously announced public offering...

Wednesday, April 7, 2021, 08:26:04 PM

Trulieve: Canaccord Reiterates $97 Price Target After Results

On November 15th, Trulieve Cannabis (CSE: TRUL) reported its third quarter results, announcing record revenues...

Friday, November 19, 2021, 10:31:00 AM

Canaccord Raises Trulieve Price Target To $75 From $60

The last two weeks have been quite an enjoyable time for U.S cannabis sector investors....

Wednesday, January 13, 2021, 02:53:00 PM